VISTAGEN THERAPEUTICS, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • June 25th, 2019 • VistaGen Therapeutics, Inc. • Pharmaceutical preparations • California
THIS AGREEMENT is entered into, effective as of November 10, 2016 between VistaGen Therapeutics, Inc., a Nevada corporation (the "Company"), and Mark A. McPartland (“Indemnitee”).
MASTER SERVICES AGREEMENT (For All CRO Services)Master Services Agreement • June 25th, 2019 • VistaGen Therapeutics, Inc. • Pharmaceutical preparations • New York
This Master Services Agreement (this “Agreement”) is made as of the 11th day of July, 2017 (the “Effective Date”) by and between Cato Research Ltd., a North Carolina corporation headquartered at 4364 South Alston Avenue, Durham, North Carolina, USA 27713 (“CRL”), and VistaGen Therapeutics, Inc., a Nevada corporation headquartered at 343 Allerton Avenue, South San Francisco, California 94080, USA (“VistaGen”). Each of CRL and VistaGen may be referred to herein separately as a “Party” and collectively as the “Parties.” As used in this Agreement, “Affiliate(s)” means any corporation, firm, partnership, or other entity which controls, is controlled by or is under common control with a Party. For the purpose of this definition, “control” shall mean the power to direct, or cause the direction of, the management and policies of an entity through the ownership, directly or indirectly, of at least fifty percent (50%) of the voting share capital of such entity or any other comparable equity, by
